Prestige Wealth Management Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77K | Buy |
38
+3
| +9% | +$377 | ﹤0.01% | 566 |
|
|
2025
Q1 | $4.79K | Hold |
35
| – | – | ﹤0.01% | 567 |
|
|
2024
Q4 | $5.35K | Sell |
35
-4
| -10% | -$612 | ﹤0.01% | 580 |
|
|
2024
Q3 | $7.56K | Sell |
39
-14
| -26% | -$2.71K | ﹤0.01% | 512 |
|
|
2024
Q2 | $12.3K | Sell |
53
-10
| -16% | -$2.32K | ﹤0.01% | 375 |
|
|
2024
Q1 | $13.6K | Sell |
63
-3
| -5% | -$647 | ﹤0.01% | 397 |
|
|
2023
Q4 | $17.1K | Buy |
66
+15
| +29% | +$3.88K | ﹤0.01% | 354 |
|
|
2023
Q3 | $13.1K | Buy |
51
+5
| +11% | +$1.29K | ﹤0.01% | 391 |
|
|
2023
Q2 | $13.1K | Buy |
46
+14
| +44% | +$3.99K | ﹤0.01% | 415 |
|
|
2023
Q1 | $8.9K | Sell |
32
-5
| -14% | -$1.39K | ﹤0.01% | 454 |
|
|
2022
Q4 | $10.2K | Sell |
37
-1
| -3% | -$277 | ﹤0.01% | 460 |
|
|
2022
Q3 | $10K | Buy |
38
+3
| +9% | +$789 | ﹤0.01% | 411 |
|
|
2022
Q2 | $7K | Hold |
35
| – | – | ﹤0.01% | 492 |
|
|
2022
Q1 | $7K | Sell |
35
-3
| -8% | -$600 | ﹤0.01% | 529 |
|
|
2021
Q4 | $9K | Buy |
38
+1
| +3% | +$237 | ﹤0.01% | 495 |
|
|
2021
Q3 | $10K | Hold |
37
| – | – | ﹤0.01% | 482 |
|
|
2021
Q2 | $13K | Sell |
37
-17
| -31% | -$5.97K | ﹤0.01% | 424 |
|
|
2021
Q1 | $15K | Sell |
54
-1
| -2% | -$278 | ﹤0.01% | 394 |
|
|
2020
Q4 | $13K | Buy |
55
+30
| +120% | +$7.09K | ﹤0.01% | 406 |
|
|
2020
Q3 | $7K | Hold |
25
| – | – | ﹤0.01% | 487 |
|
|
2020
Q2 | $7K | Sell |
25
-169
| -87% | -$47.3K | ﹤0.01% | 471 |
|
|
2020
Q1 | $62K | Sell |
194
-1,122
| -85% | -$359K | 0.03% | 157 |
|
|
2019
Q4 | $390K | Sell |
1,316
-16
| -1% | -$4.74K | 0.21% | 75 |
|
|
2019
Q3 | $310K | Sell |
1,332
-50
| -4% | -$11.6K | 0.18% | 85 |
|
|
2019
Q2 | $323K | Buy |
1,382
+419
| +44% | +$97.9K | 0.2% | 79 |
|
|
2019
Q1 | $227K | Sell |
963
-53
| -5% | -$12.5K | 0.14% | 107 |
|
|
2018
Q4 | $306K | Buy |
+1,016
| New | +$306K | 0.23% | 80 |
|